Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

23 May 2024 : Database Analysis  

MRTO4 Enhances Glycolysis to Facilitate HCC Progression by Inhibiting ALDOB

Yongyuan Zheng1ABCD, Yansong Huang1CDE, Weibing Li1CD, Hongqiu Cheng1AEG*

DOI: 10.12659/MSM.944685

Med Sci Monit 2024; 30:e944685

Figure 6 Knockdown of MRTO4 negatively regulated ALDOB to inhibit glycolysis. (A) Heatmap showing the top 35 genes in liver cancer that were positively and negatively related to MRTO4. Red represents positively related genes and blue represents negatively related genes. (B) Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses of MRTO4-related genes in HCC. (C) RT-qPCR assayed the expression of ALDOB. (D) Immunofluorescence analyzed the expression levels of ALDOB in the cells. (E) Protein imprint measured ALDOB expression in HCC cells. (F) Seahorse extracellular flux analyzer assessed the ECAR of HepG2 and MHCC97H. (G) ELISA assessed the cells for glucose consumption. (H) ELISA assessed the cellular lactate production capacity. (I) ELISA assessed the level of ATP released from the cells. All results are presented as mean±SD (n=3).* P<0.05, ** P<0.01, *** P<0.001.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750